Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Hester Biosciences has informed that CARE Ratings, with its letter dated 8 January 2020 (received by Company on 9 January 2020), has revised the ratings to the Company. The revision in credit ratings were issued due to additional term loan facility sanctioned by the Bank.
The above information is a part of company’s filings submitted to BSE.